Jane Street Group, LLC Onconova Therapeutics, Inc. Transaction History

Jane Street Group, LLC

$88.2 Billion
Q2 2024

A detailed history of Jane Street Group, LLC transactions in Onconova Therapeutics, Inc. stock. As of the latest transaction made, Jane Street Group, LLC holds 25,062 shares of ONTX stock, worth $14,786. This represents 0.0% of its overall portfolio holdings.

Number of Shares

25,062

Holding current value

$14,786

% of portfolio

0.0%

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$0.57 - $1.0 $14,285 - $25,062	25,062 New	25,062 $14,000
Q1 2023 May 15, 2023	SELL	$0.69 - $1.42 $3,345 - $6,884	-4,848 Reduced 31.99%	10,308 $7,000
Q4 2022 Feb 14, 2023	BUY	$0.63 - $0.97 $9,548 - $14,701	15,156 New	15,156 $9,000
Q2 2022 Aug 16, 2022	BUY	$1.04 - $1.9 $15,576 - $28,456	14,977 New	14,977 $20,000

Others Institutions Holding ONTX

# of Institutions

Shares Held

1.67M

Call Options Held

Put Options Held

View Full List

About Onconova Therapeutics, Inc.

Ticker ONTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,895,600
Market Cap $12.3M
Description
Onconova Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing novel products to treat cancer. It has two clinical-stage programs, including narazaciclib (ON 123300), a multi-targeted kinase inhibitor that is in Phase I study for solid tumors, as well as hematological malignancies as a single agent...

More about ONTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.

Account

Jane Street Group, LLC Onconova Therapeutics, Inc. Transaction History